Podcast Episodes
Back to SearchBiotech Capital Markets Forecast With Allan Shaw
We love to hear from our listeners. Send us a message.
As Allan Shaw likes to say, "there have never been so many people with their hands out, and th…
3 years, 11 months ago
Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias
We love to hear from our listeners. Send us a message.
The JDRF's T1D Fund is exemplary of an indication-specific advocacy group's aggressive pursuit…
4 years ago
Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo
We love to hear from our listeners. Send us a message.
Locus Biosciences CEO Paul Garofolo built his biotech leadership career on the back of an MIS …
4 years ago
Bioengineering Human Tissue With Humacyte's Dr. Heather Prichard
We love to hear from our listeners. Send us a message.
Humacyte COO Dr. Heather Prichard joins the Business of Biotech for a discussion on the compan…
4 years ago
The Top Stories Of 2021 With Allan Shaw
We love to hear from our listeners. Send us a message.
Join your host Matt Pillar and guest Allan Shaw for a no-hold-barred retrospective on the year…
4 years ago
Complete CAR T Manufacturing Control with Cellectis' Steve Doares
We love to hear from our listeners. Send us a message.
Cellectis' decision to build and operate its own trans-Atlantic manufacturing facilities was a…
4 years ago
Genomically-Guided Medicine with Elevation Oncology's Shawn Leland, PharmD, RPh
We love to hear from our listeners. Send us a message.
Elevation Oncology is taking a new approach to leveraging the genome to guide development of i…
4 years, 1 month ago
Inhalable mAbs & Vaccines with TFF's Glenn Mattes
We love to hear from our listeners. Send us a message.
Glenn Mattes' TFF Pharmaceuticals is looking to break the parenteral barrier by manufacturing …
4 years, 1 month ago
Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.
We love to hear from our listeners. Send us a message.
Making powerful and curative biologic therapies accessible to patients from all walks of life,…
4 years, 1 month ago
Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.
We love to hear from our listeners. Send us a message.
In business for just a decade, Akesobio's stats are mindboggling: 20 drug development programs…
4 years, 1 month ago